Article Information
History
- August 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Nick P.G. Gauthier1,
- Cassidy Nelson2,
- Michael B. Bonsall2,
- Kerstin Locher3,4,
- Marthe Charles3,4,
- Clayton MacDonald3,4,
- Mel Krajden4,5,
- Samuel D. Chorlton4,6,*,† and
- Amee R. Manges5,7,*,†
- 1Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada
- 2Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford, United Kingdom
- 3Division of Medical Microbiology, Vancouver General Hospital, Vancouver, British Columbia, Canada
- 4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 5British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- 6BugSeq Bioinformatics Inc, Vancouver, British Columbia, Canada
- 7School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
- ↵†Corresponding authors:
Samuel D. Chorlton, MD, sam{at}bugseq.com, Amee R. Manges, MPH, PhD, amee.manges{at}ubc.ca
↵* Denotes equal contribution
Posted August 23, 2021.
Nanopore Metagenomic Sequencing for Detection and Characterization of SARS-CoV-2 in Clinical Samples
